Long Jiang

Shanghai Chest Hospital

Papers

1

Total Citations

6

H-Index

1

About

Long Jiang is an emerging surgical oncologist whose research focuses on minimally invasive thoracic surgery, particularly the comparative outcomes of robotic and thoracoscopic approaches in treating non-small cell lung cancer (NSCLC). His work addresses a clinically critical question in modern thoracic surgery: whether robotic lobectomy offers meaningful advantages over conventional video-assisted thoracoscopic surgery (VATS) in oncologically complex cases involving lymph node involvement. Jiang's most notable contribution examines the quality of lymph node dissection and early recurrence rates in robotic versus thoracoscopic lobectomy for stage N1-2 NSCLC, drawing on eleven years of real-world data from a high-volume surgical center. This longitudinal perspective provides rare, practice-informing evidence in a field often limited by short follow-up periods and small sample sizes. The study has already attracted 6 citations since its 2024 publication, signaling early traction within the thoracic surgery community. His research is particularly valuable for surgeons and oncologists navigating the ongoing debate around surgical platform selection, offering data-driven guidance that could directly influence treatment protocols and patient outcomes in lung cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Quality of lymph node dissection and early recurrence in robotic versus thoracoscopic lobectomy for stage N1-2 non-small cell lung cancer: Eleven-year real-world data from a high-volume center
6 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Shanghai Chest Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago